The field of Dental Sleep Medicine is evolving rapidly. Because patients are becoming increasingly aware of the treatment of OSA with oral appliances, it is estimated that the number of dental devices delivered in the next 5 years will increase by 15.7 % yearly. Learn more.

The authors tested the hypothesis that obstructive sleep apnea (OSA) signs/symptoms are associated with the occurrence of temporomandibular disorder (TMD), using the OPPERA prospective cohort study of adults aged 18 to 44 years, Learn more.

The objective of this study was to evaluate the effect of oral appliance (OA) treatment on cognitive functions in patients with obstructive sleep apnea (OSA). Materials and methods: In a prospective study, 50 male patients with verified moderate-to- severe OSA received an OA with mandibular advancement. The cognitive functions assessed included working memory, vigilance, executive functioning, and mental pace, measured before as well as after 6 months of treatment. Somnograph

Background: Obstructive sleep apnea (OSA) is an independent risk factor for the development of hypertension. However the effect of continuous positive airway pressure (CPAP) on lowering systemic blood pressure (BP) in OSA patients has been conflicting. Oral appliance (OA) therapy is an important alternative therapy to CPAP for patients with mild to moderate OSA. objective: To conduct a meta-analysis of studies which have evaluated the effect of OAs on BP in patients with OSA.

Obstructive sleep apnea (OSA) is an independent risk factor for the development of hypertension. However the effect of continuous positive airway pressure (CPAP) on lowering systemic blood pressure (BP) in OSA patients has been conflicting. Oral appliance (OA) therapy is an important alternative therapy to CPAP for patients with mild to moderate OSA. objective: To conduct a meta-analysis of studies which have evaluated the effect of OAs on BP in patients with OSA. Learn more.

Rationale: Continuous positive airway pressure (CPAP) and mandibular advancement device (MAD) therapy are commonly used to treat obstructive sleep apnea (OSA). Differences in efficacy and compliance of these treatments are likely to influence improvements in health outcomes. Learn more.

Oral Appliance Therapy versus Nasal Continuous Positive Airway Pressure in Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Trial Ghizlane Aaraba Frank Lobbezooa Hans L. Hamburgerb Machiel Naeijea Previous randomized controlled trials have addressed the efficacy of mandibular advancement devices (MADs) in the treatment of obstructive sleep apnea (OSA). Their common control condition, nasal continuous positive airway pressure (nCPAP), was frequently found to be superi

Efficacy of Positive Airway Pressure and Oral Appliance in Mild to Moderate Obstructive Sleep Apnea The efficacy of currently recommended treatments is uncertain in patients with mild to moderate obstructive sleep apnea (apnea– hypopnea index [AHI], 5–30). A group of 114 sleep clinic patients with an AHI of 5–30 have participated in a randomized controlled crossover trial of 3 months of treatment with each of nasal continuous positive airway pressure (CPAP), a mandibular adva

Oral Appliance Therapy for OSA: The Facts Studies have demonstrated that OAT effectively treats OSA through reduction in apnea-hypopnea index (AHI) and respiratory disturbance index in patients. 1,2 Studies have demonstrated similar effectiveness between OAT and CPAP, even among patients with moderate-to-severe OSA.3 Learn more.

New knowledge of obstructive sleep apnea (OSA) pathophysiology has highlighted the heterogeneity of this common chronic health condition. Recent advances in OSA ‘phenotyping’ concepts have provided a novel framework in which to understand OSA pathophysiology on an individual patient basis. This has also provided new potential precision medicine strategies to optimize efficacy and success rates with current OSA treatments including mandibular advancement therapy. This review s